Literature DB >> 2170248

Characteristics of cholinergic neuroeffector transmission of ganglionic and aganglionic colon in Hirschsprung's disease.

E S Vizi1, J Zséli, E Kontor, E Feher, T Verebélyi.   

Abstract

Differences in the release and content of acetylcholine and the alpha 2 adrenoceptor mediated interaction between noradrenergic and cholinergic neurons were investigated by neurochemical and pharmacological methods in aganglionic and ganglionic segments of isolated human colon taken from children suffering from Hirschsprung's disease. Both at rest and during transmural stimulation the release of acetylcholine was significantly higher in the spastic (aganglionic) segment than in the proximal dilated bowel. Significant differences were found in the tissue concentration of acetylcholine between ganglionic and aganglionic specimens. The pattern of response to transmural stimulation was also different in the spastic and dilated bowel. Transmural stimulation induced relaxation and contraction in ganglionic specimens but only contractions in aganglionic specimens. The sensitivity of the smooth muscle in the aganglionic portion to exogenous acetylcholine and to field stimulation was found to be higher than in the ganglionic portion. While noradrenaline added to the organ bath reduced the stimulation-evoked release of acetylcholine from spastic segments, via an alpha 2 adrenoceptor mediated process, yohimbine did not enhance the release. It is suggested that in Hirschsprung's disease the increased acetylcholine release, the enhanced sensitivity of smooth muscle cells to acetylcholine, and the lack of alpha 2 adrenoceptor mediated noradrenergic modulation of acetylcholine release from cholinergic interneurons might be responsible for the spasm of aganglionic segments.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170248      PMCID: PMC1378667          DOI: 10.1136/gut.31.9.1046

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

1.  Pharmacological characteristics of the ganglionic and aganglionic colon in Hirschsprung's disease.

Authors:  F Penninckx; R Kerremans
Journal:  Life Sci       Date:  1975-11-01       Impact factor: 5.037

2.  A STUDY OF HUMAN COLONIC MUSCLE IN VITRO.

Authors:  D J FISHLOCK; A G PARKS
Journal:  Br Med J       Date:  1963-09-14

3.  Congenital megacolon; a comparison of the spastic and hypertrophied segments with respect to Cholinesterase activities and sensitivities to Acetylcholine, DFP and the barium ion.

Authors:  K KAMIJO; R B HIATT; G B KOELLE
Journal:  Gastroenterology       Date:  1953-06       Impact factor: 22.682

4.  Sympathetic neurotransmitter metabolism in Hirschsprung's disease.

Authors:  R J Touloukian; V H Morgenroth; R H Roth
Journal:  J Pediatr Surg       Date:  1975-10       Impact factor: 2.545

5.  Adrenergic hyperactivity of the aganglionic colon.

Authors:  R J Touloukian; G Aghajanian; R H Roth
Journal:  J Pediatr Surg       Date:  1973-04       Impact factor: 2.545

6.  Adrenergic myenteric nerves in Hirschsprung's disease.

Authors:  A Bennett; J R Garrett; E R Howard
Journal:  Br Med J       Date:  1968-02-24

7.  Release of acetylcholine from isolated human cortical slices: inhibitory effect of norepinephrine and phenytoin.

Authors:  E S Vizi; E Pásztor
Journal:  Exp Neurol       Date:  1981-07       Impact factor: 5.330

8.  A quantitative study of acetylcholine in Hirschsprung's disease.

Authors:  H Ikawa; J Yokoyama; Y Morikawa; A Hayashi; K Katsumata
Journal:  J Pediatr Surg       Date:  1980-02       Impact factor: 2.545

9.  The action of nicotine on the circular muscle of the human ileum and colon in vitro.

Authors:  D J Fishlock; A G Parks
Journal:  Br J Pharmacol Chemother       Date:  1966-01

10.  Adrenergic innervation of bowel in Hirschsprung's disease.

Authors:  B J Gannon; H R Noblet; G Burnstock
Journal:  Br Med J       Date:  1969-08-09
View more
  3 in total

Review 1.  Hirschsprung's disease--a review.

Authors:  C M Doig
Journal:  Int J Colorectal Dis       Date:  1991-02       Impact factor: 2.571

Review 2.  Hirschsprung's disease: clinical and experimental observations.

Authors:  P Puri
Journal:  World J Surg       Date:  1993 May-Jun       Impact factor: 3.352

3.  A novel neuropeptide, pituitary adenylate cyclase-activating polypeptide (PACAP), in human intestine: evidence for reduced content in Hirschsprung's disease.

Authors:  Z Shen; L T Larsson; G Malmfors; A Absood; R Håkanson; F Sundler
Journal:  Cell Tissue Res       Date:  1992-08       Impact factor: 5.249

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.